Norwegian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
weight loss/stroke
Koblingen er lagret på utklippstavlen
15 resultater
Inhibition of fatty acid synthase as a means to reduce adipocyte mass
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention concerns the systemic administration of an inhibitor of fatty acid synthase (E.C. 2.3.1.85, FAS) by any suitable route to achieve weight loss and/or reduction of adipocyte mass without significant toxicity. Use of FAS inhibitors
Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is directed to methods for preconditioning and/or providing neuroprotection to the animal central nervous system against ischemia, neurodegeneration, trauma and metal poisoning, including associated cognitive, behavioral and
Compounds with high monoamine transporter affinity
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD
This invention relates to novel compositions with affinity for a monoamine transporter, such as the dopamine, norepinephrine, or serotonin transporter, in brain and in peripheral tissues.
BACKGROUND OF THE INVENTION
Monoamine transporters play a variety of roles, and compounds with
Compounds with high monoamine transporter affinity
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD
This invention relates to novel compositions with affinity for a monoamine transporter, such as the dopamine, norepinephrine, or serotonin transporter, in brain and in peripheral tissues.
BACKGROUND
Monoamine transporters play a variety of roles, and compounds with affinity for the
Pro-neurogenic compounds
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD
This presently disclosed embodiments relate generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death.
BACKGROUND
It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of
Pro-neurogenic compounds
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD
This presently disclosed embodiments relate generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death.
BACKGROUND
It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of
Pro-neurogenic compounds
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD
This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death.
BACKGROUND
It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of newly formed neurons
Pro-neurogenic compounds
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD
This presently disclosed embodiments relate generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death.
BACKGROUND
It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of
Pro-neurogenic compounds
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD
This presently disclosed embodiments relate generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death.
BACKGROUND
It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of
Methods for treating amyotrophic lateral sclerosis using pro-neurogenic compounds
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD
This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death.
BACKGROUND
It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of newly formed neurons
Methods for treating Parkinson's disease using pro-neurogenic compounds
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD
This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death.
BACKGROUND
It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of newly formed neurons
Anti-depression compounds
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD
This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death, more particularly use of such compounds as antidepressant agents.
BACKGROUND
It is now accepted that the adult vertebrate brain fosters
Anti-depression compounds
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD
This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death, more particularly use of such compounds as antidepressant agents.
BACKGROUND
It is now accepted that the adult vertebrate brain fosters
Anti-depression compounds
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD
This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death, more particularly use of such compounds as antidepressant agents.
BACKGROUND
It is now accepted that the adult vertebrate brain fosters
Method and device for controlling an extracorporeal blood treatment apparatus
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
FIELD OF INVENTION
The present invention relates to a method and a device for controlling an extracorporeal blood treatment apparatus, which can be operated in particular as a hemodialysis apparatus, a hemofiltration apparatus or a hemodiafiltration apparatus. Moreover, the present invention relates
Den mest komplette databasen med medisinske urter støttet av vitenskap
- Fungerer på 55 språk
- Urtekurer støttet av vitenskap
- Urtegjenkjenning etter bilde
- Interaktivt GPS-kart - merk urter på stedet (kommer snart)
- Les vitenskapelige publikasjoner relatert til søket ditt
- Søk medisinske urter etter deres effekter
- Organiser dine interesser og hold deg oppdatert med nyheter, kliniske studier og patenter
Skriv inn et symptom eller en sykdom og les om urter som kan hjelpe, skriv en urt og se sykdommer og symptomer den brukes mot.
* All informasjon er basert på publisert vitenskapelig forskning
